These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38091655)

  • 1. Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: Current strategies and future challenges.
    Ying Li CM; Li R; Drew P; Price T; Smith E; Maddern GJ; Tomita Y; Fenix K
    Cancer Treat Rev; 2024 Jan; 122():102665. PubMed ID: 38091655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
    Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
    Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
    Lin T; Song C; Chuo DY; Zhang H; Zhao J
    Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
    Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
    World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Clinical Efficacy of Dendritic Cell -cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer.
    Xu H; Qin W; Feng H; Song D; Yang X; Zhang J
    Immunol Invest; 2021 Aug; 50(6):622-633. PubMed ID: 32718264
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer.
    Fayyaz F; Yazdanpanah N; Rezaei N
    Cell Commun Signal; 2022 Mar; 20(1):41. PubMed ID: 35346234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis.
    Li CMY; Tomita Y; Dhakal B; Li R; Li J; Drew P; Price T; Smith E; Maddern GJ; Fenix KA
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37117007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection.
    Pan QZ; Zhao JJ; Yang CP; Zhou YQ; Lin JZ; Tang Y; Gu JM; Wang QJ; Li YQ; He J; Chen SP; Song MJ; Huang Y; Yang JY; Weng DS; Xia JC
    Oncoimmunology; 2020; 9(1):1752563. PubMed ID: 32363125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases.
    Li CMY; Tomita Y; Dhakal B; Tin T; Li R; Wright JA; Vrbanac L; Woods SL; Drew P; Price T; Smith E; Maddern GJ; Fenix K
    Cancer Immunol Immunother; 2024 Jan; 73(1):6. PubMed ID: 38231291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells.
    Jäkel CE; Schmidt-Wolf IG
    Expert Opin Biol Ther; 2014 Jul; 14(7):905-16. PubMed ID: 24673175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
    Sharma A; Ren X; Rosato A; Sangiolo D; Wang Z; Tettamanti S; Zhang Y; Rettinger E; Fenix KA; Sommaggio R; Cappuzzello E; Schmidt-Wolf IGH
    Cancer Immunol Immunother; 2024 Jan; 73(2):21. PubMed ID: 38279995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cytokine-induced killer cell treatment in colorectal cancer patients: a retrospective study.
    Zhang J; Zhu L; Zhang Q; He X; Yin Y; Gu Y; Guo R; Lu K; Liu L; Liu P; Shu Y
    Biomed Pharmacother; 2014 Jul; 68(6):715-20. PubMed ID: 25107840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models.
    Shi S; Wang R; Chen Y; Song H; Chen L; Huang G
    PLoS One; 2013; 8(6):e65757. PubMed ID: 23799045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors.
    Jäkel CE; Vogt A; Gonzalez-Carmona MA; Schmidt-Wolf IG
    J Immunol Res; 2014; 2014():897214. PubMed ID: 24741629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
    Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
    Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved activation toward primary colorectal cancer cells by antigen-specific targeting autologous cytokine-induced killer cells.
    Schlimper C; Hombach AA; Abken H; Schmidt-Wolf IG
    Clin Dev Immunol; 2012; 2012():238924. PubMed ID: 22481963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.
    Dehno MN; Li Y; Weiher H; Schmidt-Wolf IGH
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapy.
    Zhang Y; Schmidt-Wolf IGH
    J Cell Physiol; 2020 Dec; 235(12):9291-9303. PubMed ID: 32484595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.